Actively Recruiting
Telemonitoring System for Improving Continuity of Care in Patients With Chronic Coronary Syndrome (TELSINCORC)
Led by Catcronic Salut SL · Updated on 2024-06-04
160
Participants Needed
1
Research Sites
44 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In a randomized clinical trial, a comprehensive telerehabilitation system with a prolonged follow-up strategy demonstrated superiority over a control group with centre-based cardiac rehabilitation in terms of physical activity, VO2 max, adherence to a Mediterranean diet, lipid particle profile and cost-effectiveness. The aim of this study is to demonstrate an extension of the benefit to patients with chronic coronary syndrome in primary care.
CONDITIONS
Official Title
Telemonitoring System for Improving Continuity of Care in Patients With Chronic Coronary Syndrome (TELSINCORC)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Patients of both sexes after more than one year of an acute coronary syndrome
- Age equal to or less than 72 years
You will not qualify if you...
- Refusal of informed consent
- Advanced biological age
- Kidney failure with GFR less than 30 ml/min/1.73 m2
- Liver failure with GOT more than 2 times normal value
- Ejection fraction less than 50%
- Uncontrolled blood pressure over 140/90 mmHg
- Uncontrolled heart failure
- Dissecting aortic aneurysm
- Uncontrolled ventricular tachycardia or other dangerous ventricular arrhythmias
- Aortic or mitral valve disease
- Recent systemic or pulmonary embolism
- Active or recent thrombophlebitis
- Acute infectious diseases
- Uncontrolled supraventricular arrhythmias or tachycardia
- Repeated or frequent ventricular ectopic activity
- Moderate pulmonary hypertension
- Ventricular aneurysm
- Uncontrolled diabetes, thyrotoxicosis, or myxedema
- Conduction disorders such as complete atrioventricular block or left bundle branch block
- Wolf-Parkinson-White syndrome
- Fixed rate pacing
- Severe anemia
- Psychoneurotic disorders
- Neuromuscular, musculoskeletal, or arthritic disorders that may limit activity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Arnau de Vilanova
Valencia, Spain, 46015
Actively Recruiting
Research Team
E
Ernesto Dalli Peydró, MD
CONTACT
J
Juan Cosín-Sales, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here